Demis Hassabis, co-founder of Google DeepMind, is stepping back from daily CEO duties to concentrate on advancing artificial general intelligence (AGI), scientific research, and his AI drug discovery startup, Isomorphic Labs. This leadership change reflects the tension between Hassabis' long-term scientific ambitions and Google's urgent need to commercialize AI technology amid fierce competition from rivals like OpenAI and Anthropic. Hassabis believes AGI is near and aims to balance responsible AI development with the pressure to scale and monetize AI products quickly. The move signals a strategic shift to integrate DeepMind's scientific goals with Google's broader AI commercialization efforts.
Mirendil, an AI startup focused on self-improving AI, has secured a multi-year partnership with Google Cloud worth over $100 million. This deal grants Mirendil access to Google’s TPUs, Nvidia GPUs, and managed training clusters to develop AI that can...
AMD's stock price fell sharply after its latest earnings report, despite beating analyst expectations on key metrics. The short volume ratio hit a two-week high of 62.60, indicating increased bearish sentiment among investors. The decline may be link...
Google is facing a challenge balancing its booming cloud business, which grew 82% in Q2, with its commitment to frontier AI research. Key AI leaders like Jeff Dean and Demis Hassabis are stepping down or shifting roles, raising concerns about Google'...
The iShares Expanded Tech Sector ETF (IGM) provides wider tech sector exposure than the traditional XLK ETF, including communications, consumer discretionary, and non-S&P 500 North American firms. This broader mandate results in a lower forward price...
Google announced a major change in its AI leadership with Jeff Dean, its chief scientist for 27 years, leaving to start a new AI startup called Discovery Loop. Demis Hassabis, CEO of Google DeepMind, will become Google's chairman and chief scientist,...
